PATENT CLAIM ANALYSIS

Application Number: 16042827
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "210160"]

Abstract:
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of malaria.

Claim (Index 13):
The pharmaceutical composition according to  claim 10 , wherein R 3  is \u2014NR 5 R 6 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.37143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15035044', '14900245', '15829243', '10481663', '11592718']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7482742778954082
- 35 USC 102 Novelty (BERT): 0.5643960412981245
- Combined Prediction Score: 0.7298864542356799
- Mean Citation Score: 288.284066
- Max Citation Score: 491.62646
- Similarity Product: 280.3116184747863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test